Pharmacy
A more concerted effort by pharmaceutical companies to drive medication adherence could help them increase their sales growth and margin profile.
Practice of PBMs being financially rewarded by drug manufacturers for setting higher prices needs to end, he says.
Kaiser Permanente found that hospitals can bolster patient satisfaction scores and increase revenue by decreasing levels of opioid prescriptions.
Even after taking into account manufacturer rebates, spending still increased more than 60 percent and the ranks of beneficiaries paying $2,000 out-of-pocket a year doubled, the Office of the Inspector General says.
Program is a crucial part of operations for hospitals that serve vulnerable populations because it offsets the high costs medications.
Brand drug manufacturers are delaying the development and entry of generics, federal officials say.
New research found that 90 percent of providers would purchase medications from the joint venture with SSM and Trinity Health but one group is not so thrilled about the novel approach.
Lone physician at family clinic charged with 19 counts of distribution of controlled substances, including opioids, as well as defrauding Medicare and Medicaid.
Specialists say legislation is needed to grow workforce and hold pharmacy benefit managers accountable for driving prices up for consumers.
CMS existing policy requires plan sponsors to ensure enrollees pay the lesser of the Part D negotiated price or copay.